Mycobacterium tuberculosis
"Mycobacterium tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.
| Descriptor ID |
D009169
|
| MeSH Number(s) |
B03.510.024.049.525.500.702 B03.510.460.400.410.552.552.702
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium tuberculosis".
This graph shows the total number of publications written about "Mycobacterium tuberculosis" by people in this website by year, and whether "Mycobacterium tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 5 | 5 |
| 1996 | 2 | 1 | 3 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 3 | 0 | 3 |
| 2001 | 7 | 0 | 7 |
| 2002 | 1 | 1 | 2 |
| 2003 | 8 | 3 | 11 |
| 2004 | 6 | 2 | 8 |
| 2005 | 9 | 2 | 11 |
| 2006 | 4 | 4 | 8 |
| 2007 | 5 | 2 | 7 |
| 2008 | 5 | 3 | 8 |
| 2009 | 8 | 4 | 12 |
| 2010 | 4 | 3 | 7 |
| 2011 | 12 | 9 | 21 |
| 2012 | 7 | 3 | 10 |
| 2013 | 11 | 0 | 11 |
| 2014 | 11 | 5 | 16 |
| 2015 | 8 | 6 | 14 |
| 2016 | 16 | 10 | 26 |
| 2017 | 13 | 11 | 24 |
| 2018 | 12 | 5 | 17 |
| 2019 | 7 | 6 | 13 |
| 2020 | 11 | 5 | 16 |
| 2021 | 10 | 2 | 12 |
| 2022 | 18 | 0 | 18 |
| 2023 | 9 | 1 | 10 |
| 2024 | 12 | 5 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycobacterium tuberculosis" by people in Profiles.
-
The molecular bacterial load assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/Rif. J Infect. 2025 Feb; 90(2):106399.
-
Effectiveness of the primary Bacillus Calmette-Gu?rin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data. Lancet Microbe. 2025 Feb; 6(2):100961.
-
Whispers in the Wind: Face Mask Sampling for Mycobacterium tuberculosis Detection in Children With Pulmonary Tuberculosis. J Infect Dis. 2024 Dec 16; 230(6):1510-1517.
-
Strategies to Enhance Diagnostic Capabilities for the New Drug-Resistant Tuberculosis (DR-TB) Drugs. Pathogens. 2024 Nov 28; 13(12).
-
TCA metabolism regulates DNA hypermethylation in LPS and Mycobacterium tuberculosis-induced immune tolerance. Proc Natl Acad Sci U S A. 2024 Oct 08; 121(41):e2404841121.
-
Bedaquiline: what might the future hold? Lancet Microbe. 2024 Dec; 5(12):100909.
-
Candidate anti-tuberculosis medicines and regimens under clinical evaluation. Clin Microbiol Infect. 2024 Sep; 30(9):1131-1138.
-
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe: author's response. Clin Microbiol Infect. 2024 Sep; 30(9):1207-1208.
-
Parallel use of low-complexity automated nucleic acid amplification tests on respiratory samples and stool with or without lateral flow lipoarabinomannan assays to detect pulmonary tuberculosis disease in children. Cochrane Database Syst Rev. 2024 May 13; 5:CD016071.
-
Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles. Lancet Microbe. 2024 Sep; 5(9):100869.